The company has developed an AI-powered platform that automates the optimization of personalized medication treatment.
Israeli medication optimization company MDI Health has completed a $20 million Series A financing round led by Intel Capital with participation from Maverick Ventures Israel and existing investors Hanaco Ventures, Welltech Ventures, Arc Impact, Basad Ventures, Fresh.Fund, Jumpspeed Ventures and former SVP of Optum Richard Montwill. This brings the amount raised by MDI Health to $26 million.